Several companies are evaluating Messenger Biopharma’s Aegis biotechnology

photo animalerie 3

posted Sep 03 2018

From this Summer on, a few companies, dedicated to research & development of mRNA vaccines and drugs, are testing our uncapped mRNA, in order to strongly decrease the production cost of their future pharmaceutical products.

Following this step of evaluation, Messenger Biopharma will out-license its Aegis biotechnology to these first partners.